Has Morad Nasseri, MD received payments from drug or device companies?

Yes. Drug and device makers reported $90,702 in general payments to Morad Nasseri, MD across 486 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Morad Nasseri, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Morad Nasseri, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Morad Nasseri, MD

Neurology · Walnut Creek, CANPI 1154615565

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (40.2%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. 32 manufacturers reported payments, led by Saluda Medical Americas, Inc. at 29.5% of the total. 2025 is the largest year on record at $33,845, more than ten times the $170 reported in 2019. Among neurology clinicians in CA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$90,702in general payments, 2019–2025

Across 486 payments — averaging $186.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Saluda Medical Americas, Inc.$27K
Nevro Corp.$26K
Abbott$8K
Globus Medical$7K
Si-bone, Inc.$3K
Medtronic$3K
plus $16K from 26 others

$18,800in research payments, 2019–2025

Across 12 payments — averaging $1566.67 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Saluda Medical Americas, Inc.$19K

What the payments were for

Consulting fees$36,45540%
Speaking & faculty fees$8,5759%
Travel & lodging$23,76326%
Food & beverage$21,36524%
Education$5431%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Saluda Medical Americas, Inc.	65	$26,713
Nevro Corp.	100	$26,029
Abbott	54	$7,946
Globus Medical	31	$7,263
Si-bone, Inc.	11	$3,496
Medtronic	31	$2,940
Spinal Simplicity, LLC	26	$2,827
Boston Scientific	33	$2,759
Painteq LLC	17	$1,798
Relievant Medsystems, Inc.	12	$1,696
SPR Therapeutics, Inc	15	$1,473
Nalu Medical, Inc.	13	$1,175
Biotronik NRO, Inc.	11	$1,012
MML US, Inc.	7	$979
Curonix LLC	10	$786
AbbVie	11	$339
AstraZeneca	3	$265
Vertos Medical, Inc.	6	$224
Bioventus LLC	5	$189
Mesoblast, Inc.	1	$178
Lilly USA, LLC	3	$122
Foundation Fusion Solutions, LLC	2	$73
Biohaven Pharmaceutical Holding Company Ltd.	3	$72
Stimwave Technologies Incorporated	1	$69
Collegium Pharmaceutical, Inc.	4	$64
Electronic Waveform Lab, Inc.	2	$45
GRT US Holding, Inc.	2	$45
Scilex Pharmaceuticals Inc.	2	$39
Pfizer	2	$36
Fidia Pharma USA Inc.	1	$19
Sanofi	1	$14
Genentech USA, Inc.	1	$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Senza$29,030
Evoke$23,140
PROCLAIM$6,637
Intracept$3,330
IFUSE IMPLANT SYSTEM$3,174
Evoke SCS$2,431
HA MINUTEMAN G3-R$2,338
Omnia$1,758
Superion Indirect Decompression System$1,176
SPRINT PNS System$1,095
SYNCHROMEDII$1,007
PAINTEQ$1,006
Nalu Neurostimulation System$864
VANTA ADAPTIVESTIM$854
ReActiv8$747
Prospera$726
PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A$564
GENERAL PAIN MANAGEMENT$213
Ryoncil$178
mild Device Kit$150

How this compares

$90,702 in reported general payments places this provider in the 90th percentile of 1,996 neurology providers in California.

See all neurology providers in California →

Medicare billing

Part B allowed, 2024

$462,423

Medicare patients

313

Services billed

4,482

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	20	$531
Gabapentin	15	$104
Cyclobenzaprine Hcl	13	$101
Cephalexin	31	$90

Paid to pharmacies, not to this prescriber.

Other neurology in Walnut Creek

Andrew BlumenfeldCarlsbad$4.9M
Khashayar DashtipourLoma Linda$3.3M
Regina BerkovichWest Hollywood$3M
Daniel BandariNewport Beach$2.6M
Perry ShiehLos Angeles$2.4M
Sandeep ThakkarIrvine$2M
David LiebeskindLos Angeles$1.9M
Jack SchimCarlsbad$1.7M
Parshaw DorrizMission Viejo$1.5M
Benjamin FrishbergCarlsbad$1.2M

See the full list for California →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →